title: Regression of Iris Metastasis After Systemic Treatment With Melanoma-Targeted Therapy.
authors.affiliation: Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal.
authors.forename: Cristina
authors.initials: C
authors.lastname: Fonseca
authors.affiliation: Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal.
authors.forename: Júlia
authors.initials: J
authors.lastname: Fernandes
authors.affiliation: Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal.
authors.forename: Rui
authors.initials: R
authors.lastname: Proença
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001384:Azetidines / Q000008:administration & dosage; D006801:Humans; D015811:Iris Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D010880:Piperidines / Q000008:administration & dosage; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000077484:Vemurafenib / Q000008:administration & dosage
chemical_list: D001384:Azetidines; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D000077484:Vemurafenib; C574276:cobimetinib